Describe the clinical and practical benefits of biosimilars in IBD management, with emphasis on affordability and improved treatment access Evaluate ongoing challenges to biosimilar integration in IBD care and outline strategies to improve biosimilar access Assess the current biosimilar approval and regulatory landscape that impacts market access, adoption, and availability, including recent policy developments Analyze current evidence on the safety and effectiveness of biosimilars for the treatment of IBD
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 104 Windsor Center Drive
Pricing
CME included with membership · $99–598/yr
| New Membership – Standard | $349/yr |
| New Membership – Standard (2-year) | $598/yr |
| New Membership – Military/VA | $259/yr |
| New Membership – Student/Resident | $149/yr |
| Renewal Membership – Standard | $249/yr |
| Renewal Membership – Standard (2-year) | $478/yr |
+27 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- Child & Adolescent Psychiatry
- Clinical Informatics
- Communication & Shared Decision-Making
- General & Adult Psychiatry
- General Surgery
- Interventional Radiology
- Mood & Anxiety Disorders
- Neurology
- Neuroradiology
- Nuclear Medicine
- Pain Medicine
- Pediatric Neurology
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Sleep Medicine
- Cross-Specialty
- Medical Subspecialties
- Neurology
- Pain & Palliative
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Commercial Support
-
ReleasedJan 12, 2026
-
Last day to claim creditJan 13, 2027 3 months left
-
HMP Education Novel Strategies to Advance IBD Care: A Focus on the Role of IL-23 Inhibitors for the Management of Crohn s Disease and Ulcerative Colitis
-
HMP Education Subcutaneous Therapies in IBD: Evidence, Patient Selection, and Practical Approaches to Optimizing Outcomes
-
HMP Education Targeting TNF in IBD: Innovations in Drug Design, Delivery, and Clinical Application
